{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Established Pharmacologic Class [EPC]" in comments (approximate match)
Status:
US Approved Rx
(2001)
First approved in 1977
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2016)
Source:
NDA207648
(2016)
Source URL:
First approved in 1975
Source:
INTRALIPID 10% by FRESENIUS
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(1971)
First approved in 1971
Source:
BLA101069
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(1971)
First approved in 1971
Source:
BLA101069
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(1971)
First approved in 1971
Source:
BLA101069
Source URL:
Class:
STRUCTURALLY DIVERSE